Interleukin 2 Expanded Tumor-infiltrating Lymphocytes in Human Renal Cell Cancer: Isolation, Characterization, and Antitumor Activity

Cancer Research

Volumn 48, Issue 1, 1988, Pages 206-214

  Belldegrun, Arie ^a   Muul, Linda M ^a   Rosenberg, Steven A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; INTERLEUKIN 2;

ANTINEOPLASTIC ACTIVITY; CYTOLOGY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; LYMPHOCYTIC INFILTRATION;

ADULT; AGED; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CARCINOMA, RENAL CELL; CELL SEPARATION; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HLA-DR ANTIGENS; HUMAN; IMMUNOTHERAPY; INTERLEUKIN-2; KIDNEY NEOPLASMS; LYMPHOCYTES; MALE; MIDDLE AGE; PHENOTYPE;

EID: 0023880178     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Rosenberg, S. A. Adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2. In: V. T. Devita, S. Hellman and S. A. Rosenberg (eds.), Important Advances in Oncology, pp. 55–91. New York: J. B. Lippincott, 1986.
2. Rosenberg, S. A. Lymphokine activated killer cells: a new approach to the immunotherapy of cancer. J. Natl. Cancer Inst., 75; 595-603,1985.
3. Mule, J. J., Shu, S., Schwarz, S. L., and Rosenberg, S. A. Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Science (Wash. DC), 225:1487-1489,1984.
4. Lafreniere, R., and Rosenberg, S. A. Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2. Cancer Res., 45:3735-3741,1985.
5. Rosenberg, S. A., Lotze, M. T., Muul, L. M., Leitman S., Chang, A. E., Ettinghausen, S. E., Matory, Y. L., Skibber, J. M., Shiloni, E., Vetto, J. T., Seipp, C. A., Simpson, C., and Reichert, C. M. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N. Engl. J. Med., 313: 1485-1492,1985.
6. Rosenberg, S. A. Adoptive immunotherapy of cancer accomplishments and prospects. Cancer Treat. Rep., 68:233-255,1984.
7. Rosenberg, S. A., Spiess, P., and Lafreniere, R. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science (Wash. DC), 233:1318-1321,1986.
8. Salup, P. R., and Wiltrout, R. H. Adjuvant immunotherapy of established murine renal cancer by interleukin 2-stimulated cytotoxic lymphocytes. Cancer Res., 46: 3358-3363,1986.
9. Rosenberg, S. A., Grimm, E. A., McGrogan, M., Doyle, M., Kawasaki, E., Koths, K., and Mark, D. F. Biological activity of recombinant human interleukin-2 produced in E. coli. Science (Wash. DC), 223: 1412–1414, 1984.
10. Boyum, A. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest., 21:77-89,1968.
11. Vose, B. M., Vanky, F., and Klein, E. Human tumor-lymphocyte interaction in vitro. V. Comparison of the reactivity of tumor infiltrating blood and lymph node lymphocytes with autologous tumor cells. Int. J. Cancer, 20: 895–902, 1977.
12. Totterman, T. H., Hayry, P., Saksela, E., Timonen, T., and Eklund, B. Cytological and functional analysis of inflammatory infiltrates in human malignant tumors. Eur. J. Immunol., 8:872-875, 1978.
13. Vose, B. M., and Moore, M. Suppressor cell activity of lymphocytes infiltrating human lung and breast tumors. Int. J. Cancer, 24:579-585, 1979.
14. Eremin, O., Coombs, R. R. A., and Ashby, J. Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity. Br. J. Cancer, 44:166-176,1981.
15. Moy, P. M., Holmes, E. C., and Golub, S. H. Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors. Cancer Res., 45:57-60, 1985.
16. Rabinowich, H., Cohen, R., Buderman, I., et al. Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes. Cancer Res., 47:173-177, 1987.
17. Klein, E., Vanky, F., Galili, U., Vose, B. M., and Fopp, M. Separation and characteristics of tumor infiltrating lymphocytes in man. In: I. P. Witz and M. G. Hanna, Jr. (eds.), Contemporary Topics in Immunobiology, Vol. 10, pp. 79–107. New York: Plenum Press, 1980.
18. Vose, B. M. Quantitation of proliferative and cytotoxic precursor cells directed against human tumors: limiting dilution analysis in peripheral blood and at the tumor site. Int. J. Cancer, 30:135-142,1982.
19. Keong, A., and Rabson, A. R. Supernatants derived from a human hepatocellular carcinoma cell line (PLC/PRF/5) activates a population of T-sup-pressor cells. Cancer Immunol. Immunother., 15:178-183,1983.
20. Miescher, S., Whiteside, T. L., Carrel, S., and Fliedner, V. Functional properties of tumor infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J. Immunol., 136:1899-1907,1986.
21. Vose, B. M., Ferguson, R., and Moore, M. Mitogen responsiveness and inhibitory activity of mesenteric lymph node cells. Cancer Immunol. Immu-nother., 13: 105-111,1982.
22. Yron, I., Wood, T. A., Spiess, P. J., and Rosenberg, S. A. In vivo growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors. J. Immunol., 125:238-245, 1980.
23. Muul, L. M., Spiess, P. J., Director, E. P., and Rosenberg, S. A. Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J. Immunol., 138:989-995,1987.
24. Itoh, K., Tilden, A. B., and Balch, C. M. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas. Cancer Res., 46: 3011–3017, 1986.
25. Vose, B. M., and Moore, M. Cultured human T cell lines kill autologous solid tumors. Immunol. Lett., 3:237-241,1981.
26. Yang, J., Mule, J. J., and Rosenberg, S. A. Murine lymphokine-activated killer (LAK) cells: phenotypic characterization of the precursor and effector cells. J. Immunol., 137:715-722, 1986.
27. Colotta, F., Rambaldi, A., Colombo, N., Tabacchi, L., Introma, M., and Mantovani, A. Effect of a streptococcal preparation (OK 432) on natural killer activity of tumor-associated lymphoid cells in human ovarian carcinoma and on lysis of fresh ovarian tumor cells. Br. J. Cancer, 45:515-525,1983.